Literature DB >> 27038366

Differences in health-related quality of life between European and Asian patients with hepatocellular carcinoma.

Wei-Chu Chie1, Jane M Blazeby2,3, Chin-Fu Hsiao4, Herng-Chia Chiu5, Ronnie T Poon6, Naoko Mikoshiba7, Gillian Al-Kadhim8, Nigel Heaton8, Jozer Calara8, Peter Collins9, Katharine Caddick9, Anna Costantini10, Valerie Vilgrain11,12.   

Abstract

AIM: The aim of this study is to explore the possible effects of clinical and cultural characteristics of hepatocellular carcinoma on patients' health-related quality of life (HRQoL).
METHODS: Patients with hepatocellular carcinoma from Asian and European countries completed the EORTC QLQ-C30 and the EORTC QLQ-HCC18. Comparisons were made using Student's t-test and Wilcoxon rank-sum test with method of false discovery to correct multiple comparisons. Multiway analysis of variance and model selection were used to assess the effects of clinical characteristics and geographic areas.
RESULTS: Two hundred and twenty-seven patients with hepatocellular carcinoma completed questionnaires. After adjusting for demographic and clinical characteristics, Asian patients still had significantly better HRQoL scores in emotional functioning, insomnia, (QLQ-C30) and in sexual interest (QLQ-HCC18). We also found an interaction in physical functioning (QLQ-C30) and fatigue (QLQ-HCC18) between geographic region and marital status, married European had worse HRQoL scores than Asian singles.
CONCLUSIONS: Both clinical characteristics and geographic areas affected the HRQoL in with hepatocellular carcinoma. Cultural differences and clinical differences in the pattern of disease due to active surveillance of Asian countries may explain the results.
© 2016 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  cultural difference; hepatocellular carcinoma; quality of life; the EORTC questionnaire

Mesh:

Year:  2016        PMID: 27038366     DOI: 10.1111/ajco.12464

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN: 1743-7555            Impact factor:   2.601


  6 in total

Review 1.  Disease Burden of Hepatocellular Carcinoma: A Global Perspective.

Authors:  Mehmet Sayiner; Pegah Golabi; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

Review 2.  A closer look at quality of life in the hepatocellular carcinoma literature.

Authors:  Jenny L Firkins; Robin Tarter; Martha Driessnack; Lissi Hansen
Journal:  Qual Life Res       Date:  2021-02-24       Impact factor: 4.147

Review 3.  Value of quality of life analysis in liver cancer: A clinician's perspective.

Authors:  Leung Li; Winnie Yeo
Journal:  World J Hepatol       Date:  2017-07-18

4.  Psychometric validation of the EORTC QLQ-HCC18 in patients with previously treated unresectable hepatocellular carcinoma.

Authors:  Daniel Serrano; Lauren Podger; Gisoo Barnes; James Song; Boxiong Tang
Journal:  Qual Life Res       Date:  2021-09-13       Impact factor: 4.147

Review 5.  Systematic Review of Studies Assessing the Health-Related Quality of Life of Hepatocellular Carcinoma Patients from 2009 to 2018.

Authors:  Danbee Kang; Sungkeun Shim; Juhee Cho; Hyo Keun Lim
Journal:  Korean J Radiol       Date:  2020-06       Impact factor: 3.500

6.  Health-related quality of life in primary hepatic cancer: a systematic review assessing the methodological properties of instruments and a meta-analysis comparing treatment strategies.

Authors:  Kerstin Wohlleber; Patrick Heger; Pascal Probst; Christoph Engel; Markus K Diener; André L Mihaljevic
Journal:  Qual Life Res       Date:  2021-07-20       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.